CD8A and neoplasm: In the tumor microenvironment, RNA modifications act as critical determinants of CD8+ T cell persistence, metabolic fitness, and responsiveness to immunotherapy, with distinct regulatory enzymes exerting either supportive or suppressive effects on antitumor immunity 102-104.